resveratrol has been researched along with Carcinoma, Ductal, Breast in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennington, JL; Dairkee, SH; Luciani-Torres, G; Meng, Z; Moore, DH; Sayeed, A | 1 |
| Barrajón-Catalán, E; Catania, A; Cicirata, F; Micol, V; Nicolosi, S | 1 |
| Bhat, KP; Christov, K; Lantvit, D; Mehta, RG; Moon, RC; Pezzuto, JM | 1 |
3 other study(ies) available for resveratrol and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
Topics: Antigens, CD; Antineoplastic Agents, Hormonal; Apoptosis; Base Sequence; Binding Sites; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fatty Acid-Binding Proteins; Female; Gene Expression; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Kaplan-Meier Estimate; Molecular Sequence Data; Promoter Regions, Genetic; Proportional Hazards Models; Protein Binding; Resveratrol; Stilbenes; Tamoxifen; Transforming Growth Factor beta | 2013 |
Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.
Topics: Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Agents; Biological Availability; Biological Products; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Line, Tumor; Cholesterol; Chromatography, High Pressure Liquid; Curcumin; Drug Compounding; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunoconjugates; Liposomes; Neoplasm Proteins; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Receptor, ErbB-2; Resveratrol; Stilbenes; Trastuzumab | 2013 |
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Carcinoma, Ductal, Breast; Estrogens; Female; Humans; Luciferases; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Inbred BALB C; Organ Culture Techniques; Protein Biosynthesis; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Response Elements; Resveratrol; Selective Estrogen Receptor Modulators; Stilbenes; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2001 |